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ABSTRACT
We report a case of carcinoma of the esophagus in a 58 years old woman with achalasia, who has been diagnosed since
30 years ago, which initiated by surgical treatment (myotomy) and the symptoms recurred since 3 years ago.
According to the progress of the disease, malignancy was strongly suspected due to prolonged stasis and mucosal
irritation caused by achalasia (achalasia carcinoma sequence). Because of these contributing factors for the development of
serious complications such as malignancy, the diagnosis of achalasia must be systematically diagnosed and treated
agressively. Surveillance endoscopy in patients with achalasia should be performed every 1-2 years.
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INTRODUCTION
Achalasia is a disease in which there is a double de-
fect in esophageal function, including inappropriate lower
esophageal sphincter (LES) relaxation and loss of
peristaltis in the lower two thirds of the smooth muscle
portion of the esophagus.
We can detect abnormalities in muscle and nerve
component:
· Loss of ganglion cells within the myenteric
(Auerbach) plexus (the most important).
· Degeneration of the vagus nerve.
· Qualitative and quantitative changes in the dorsal
motor nucleus of the vagus.
The first case was reported by Sir Thomas Willis in
1672, and the term of achalasia was coined by Hurst
and Rake in 1929 who introduced bougie dilator in the
treatment of achalasia.
Between 1998-2000, there were 26 new cases of
achalasia who came to the Division of Gastroenterol-
ogy, Department of Internal Medicine, Cipto
Mangunkusumo National General Hospital Jakarta, two
of them were twins.
All of the patients had solid food dysphagia and most
of them had variable degree of liquid food dysphagia.
Other complaint were regurgitation, chest pain, heart-
burn and weight loss.
Diagnosis was made by physical examination (al-
though rare abnormalities were found), radiography
(barium meal) and endoscopy (with biopsy). Endoscopic
examination is always required to exclude a neoplastic
process at the location of the gastroesophageal junction,
and to evaluate the esophageal mucosa before thera-
peutic manipulation. The diagnosis of achalasia, if avail-
able, should be established by esophageal manometry.
Treatment:
-    diet
- pharmacotherapy (anticholinergic, isosorbid dinitrate,
calcium channel blocker)
- esophageal dilatation (Hurst bougie, savarry bougie,
pneumatic/ballon dilator)
If conservative treatment is failed, surgical treatment
(myotomy) should be considered.
The newer conservative treatment:
- Transcutaneous electric nerve stimulation (TENS)
- Injection of Botulinum toxin
CASE REPORT
A Sundanese 58 years old woman presented with
the complaint of dysphagia, especially solid food, since 3
years ago.
Actually, she has been diagnosed as achalasia since
1970 and at that time surgery (myotomy) was performed.
After the surgery, the complaints were completely re-
lieved. Since 3 years ago, she has experienced the same
complaints and it much worsened in the last year with
the loss of body weight of 20 kg.
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Physical examination: malnourished (body weight was
28 kg, height 150 cm) and conjunctiva were pale. No
other abnormalities were found.
Haemoglobin level was 4,8 g/L. Barium meal exami-
nation revealed a very dilated middle and lower part of
esophagus (sigmoid type).
Endoscopy: LES was very stenotic with dilatation of
esophageal lumen from the middle until the lower part.
The mucosa was fragile and nodular. Biopsy was per-
formed and histopatological findings revealed squamous
cell carcinoma.
Dilatation by balloon/pneumatic dilator was performed
3 times, that resulted in a relieve of symptoms. The pa-
tient refused surgical treatment.
DISCUSSION
Achalasia is uncommon but not rare. In this patient,
achalasia was already diagnosed 30 years ago, in which
initiated by surgical treatment. The symptoms started to
return 3 years ago, and worsened in the last year. The
last investigation revealed a marked esophageal dilata-
tion and the clear appearance of malignancy (squamous
cell carcinoma). Because of the progress of the disease,
the development of carcinoma in this patient was strongly
suspected due to prolonged stasis and mucosal irritation
caused by achalasia (achalasia carcinoma sequence).
The anemia occurred due to deficiency. Because marked
esophageal dilatation and stasis may be important con-
tributing factors for the development of serious compli-
cations, the diagnosis of achalasia must be systemati-
cally diagnosed and aggressively treated. Surveillance
endoscopy in patients with achalasia should be performed
every 1-2 years.
Algorithm for the treatment of low and high risk pa-
tients with achalasia as follows.
Low-risk Patients High-risk Patients
Pneumatic dilatation
Success Failure
(Early or late)
Repeat Dilatation
Failure Success
Myotomy
Success Failure
Reoperation
Pharmacotherapy
(isordil or nifedifine)
Success Failure
Bouginage
Success Failure
Repeat dilatation
Success Failure
Myotomy
Pneumatic dilatation
FailureSuccess
Figure 1. Algorithm for the treatment of low and high risk patients with achalasia
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CONCLUSION
We report a case of carcinoma of the esophagus in a
patient with achalasia, who has been diagnosed 30 years
ago, wich initiated by surgical treatment (myotomy).
The symptoms recurred 3 years ago and the investi-
gation revealed a marked dilatation of the esophagus and
stenosis of LES and a clear appearance of esophageal
malignancy.
According to the progress of disease, this malignancy
was strongly suspected due to prolonged stasis and mu-
cosal irritation caused by achalasia (achalasia carcinoma
sequence).
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